复方芩部丹方治疗气阴亏虚型耐多药肺结核35例临床观察

陆城华; 陆俊彦; 耿佩华; 郭晓燕; 薛鸿浩; 鹿振辉; 张忠顺; 张惠勇

doi:10.13288/j.11-2166/r.2014.21.008

您当前的位置：

首页 >

文章列表页 >

复方芩部丹方治疗气阴亏虚型耐多药肺结核35例临床观察

临床研究 | 更新时间：2021-11-17

- 复方芩部丹方治疗气阴亏虚型耐多药肺结核35例临床观察
- Clinical Observation on Compound Qinbu Pill for 35 Multi-drug Resistant Tuberculosis Patients with Qi-Yin Deficiency Syndrome
- 中医杂志 2014年55卷第21期页码：1826-1829
- 作者机构：
  
  1. 上海中医药大学附属龙华医院
  2. 南京医科大学第二附属医院
  3. 上海市肺科医院
- 作者简介：
- 基金信息：
  
  国家“十一五”科技重大专项资助项目（2008ZX10005-011）
- DOI：10.13288/j.11-2166/r.2014.21.008
  中图分类号： R259
- 纸质出版：2014
- 稿件说明：
移动端阅览
[1]陆城华,陆俊彦,耿佩华,郭晓燕,薛鸿浩,鹿振辉,张忠顺,张惠勇.复方芩部丹方治疗气阴亏虚型耐多药肺结核35例临床观察[J].中医杂志,2014,55(21):1826-1829.

LU Chenghua, LU Junyan, GENG Peihua, et al. Clinical Observation on Compound Qinbu Pill for 35 Multi-drug Resistant Tuberculosis Patients with Qi-Yin Deficiency Syndrome[J]. Journal of Traditional Chinese Medicine2014, 55(21): 1826-1829.
[1]陆城华,陆俊彦,耿佩华,郭晓燕,薛鸿浩,鹿振辉,张忠顺,张惠勇.复方芩部丹方治疗气阴亏虚型耐多药肺结核35例临床观察[J].中医杂志,2014,55(21):1826-1829. DOI： 10.13288/j.11-2166/r.2014.21.008.

LU Chenghua, LU Junyan, GENG Peihua, et al. Clinical Observation on Compound Qinbu Pill for 35 Multi-drug Resistant Tuberculosis Patients with Qi-Yin Deficiency Syndrome[J]. Journal of Traditional Chinese Medicine2014, 55(21): 1826-1829. DOI： 10.13288/j.11-2166/r.2014.21.008.

摘要

目的观察复方芩部丹方治疗气阴亏虚型耐多药肺结核的临床疗效。方法将72例耐多药肺结核患者随机分为治疗组和对照组各36例。对照组给予肺泰胶囊口服

每次5粒

每日3次;治疗组给予复方芩部丹方

每日1剂。两组疗程均为3个月。治疗前后对中医症状进行评分。观察两组患者中医证候疗效、单项症状疗效、不良反应。结果治疗组中医证候疗效总有效率82.86%

对照组为25.81%

治疗组明显优于对照组（P<0.01）。两组治疗后咳嗽、潮热、气短、盗汗、自汗、咯痰、咽干、消瘦积分及中医症状总积分与治疗前比较均明显下降（P<0.01）;治疗后治疗组中医症状总积分及气短、盗汗、自汗、咯痰积分均明显低于对照组（P<0.05或P<0.01）。治疗组患者气短、盗汗、自汗、咯痰疗效总有效率明显优于对照组（P<0.05或P<0.01）。两组未见不良反应。结论复方芩部丹方治疗气阴亏虚型耐多药肺结核中医临床疗效显著

在改善气短、盗汗、自汗、咯痰症状方面优于肺泰胶囊。

Abstract

Objective To observe the clinical effect of Compound Qinbu Pill in treating multi-drug resistant tuberculosis（ MDR-TB） patients with qi-yin deficiency syndrome. Methods Totally 72 cases of MDR-TB were randomized into the treatment group and control group

with 36 in each. The patients in the control group were taken Feitai Capsule orally

5 capsules each time and 3 times daily. The treatment group was given compound Qinbu Pill

one dose daily. The treatment lasted for 3 months. The clinical efficacy

TCM symptom score and adverse reactions were observed. Results The total effective rate of the treatment group and control group was 82. 86% and 25. 81%respectively

with a significant difference between groups（ P < 0. 01）. After treatment

the scores of cough

hectic fever

shortness of breath

night sweating

spontaneous sweating

expectoration

dry throat and emaciation and the total TCM symptom scores in both groups were significantly decreased（ P < 0. 01）. The total TCM symptom score and the scores of shortness of breath

night sweating

spontaneous sweating and expectoration in the treatment group were significantly lower than those in the control group after treatment（ P < 0. 05 or P < 0. 01）. The therapeutic effect of shortness of breath

night sweating

spontaneous sweating and expectoration in the treatment group was significantly better than that in the control group（ P < 0. 05 or P < 0. 01）. There was no adverse reaction in both groups.Conclusion Compound Qinbu pill has a remarkable TCM clinical effect on qi-yin deficiency type MDR-TB. It is more effective than Feitai Capsule in relieving shortness of breath

night sweating

spontaneous sweating and expectoration.

关键词

Keywords

references

查看原文

浏览量

192

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

苇石清金方治疗成人社区获得性肺炎痰热壅肺证的真实世界疗效及经济学评价——一项多中心回顾性队列研究

“天癸”与女性生殖遗传疾病相关性探究

中医药去中心化临床试验关键技术实施的挑战与建议

李果烈从“升清降浊”辨治直立性低血压经验

通便汤对慢传输型便秘模型大鼠结肠组织VAPB-PTPIP51复合物及Cajal间质细胞自噬的影响